Glial transforming growth factor (TGF)-β isotypes in multiple sclerosis: differential glial expression of TGF-β1, 2 and 3 isotypes in multiple sclerosis
Introduction
The transforming growth factor (TGF)-β family of cytokines are important modulatory molecules which influence: (1) cell proliferation, migration and maturation, (2) tissue repair and scarring, and (3) inflammatory and immune responses (Roberts and Sporn (1990), Roberts and Sporn (1992); Kulkarni et al., 1995; Sawada et al., 1995). Based upon experimental findings in the nervous system, they have been proposed to play a central position in organizing the brain's responses to varied insults (May and Finch, 1992; Finch et al., 1993; Krieglstein et al., 1995). There are three highly homologous isoforms of TGF-β in mammals: TGF-β1, 2, and 3. Despite their structural similarities these isoforms differ in respect to their expression, regulation and function (Roberts and Sporn (1990), Roberts and Sporn (1992); Geiser et al., 1993; Kulkarni et al., 1995; Sawada et al., 1995). Survey studies have described normal neonatal and adult rodent brain TGF-β message and protein cellular distributions (Sawada et al., 1995; Krieglstein et al., 1995; Unsicker et al., 1991; Pelton et al., 1991). In addition, studies in vitro have supported glial TGF-β synthesis and provided some evidence of particular isotype patterns of synthesis by astrocytes and microglia (Danielpour et al., 1989; Constam et al., 1992; daCunha and Vitkovic, 1992).
To date, there have been limited studies of the expression of this cytokine family in the lesions of either experimental allergic encephalomyelitis (EAE) or multiple sclerosis (MS) (Racke et al., 1992; Santambrogio et al., 1993; Woodroofe and Cuzner, 1993; Cannella and Raine, 1995; Johns et al., 1991). Recent studies on the cytokine profiles of T cell lines from patients with MS, on the impact of TGF-β cytokines on encephalogenic T cells harvested from patients with MS and rodents with EAE, and on clinical/pathological findings in EAE provide evidence of their ability to influence the demyelinating diseases (Johns et al., 1991; Kuruvilla et al., 1991; Racke et al. (1991), Racke et al. (1992); Weinberg et al., 1992; Santambrogio et al., 1993; Johns and Sriram, 1993; Mokhtarian et al., 1994; Link et al. (1994a), Link et al. (1994b), Link et al. (1994c), Link et al. (1995); Correale et al., 1995).
We therefore undertook the present, comparative descriptive immunohistochemical, study of the differential glial expression of the TGF-β isotypes, TGF-β 1, 2 and 3, in acute, chronic active and chronic inactive MS lesions (Cannella and Raine, 1995). In addition to internal comparisons within the MS cases, the MS results are compared to those seen in age matched normal control brains and in a pathological control, progressive multifocal leukoencephalopathy (PML), a virally induced demyelinating disease (Esiri and Kennedy, 1992). These studies extend our investigations into the patterns of glial TGF-β isotype expression in pathological processes characterized by reactive astrocytosis, microglial activation and the deposition of soluble components of the immune system (Peress and Perillo, 1995).
Section snippets
Materials and methods
In recent reports, we established that glass affixed sections of tissues fixed in 10% neutral buffered formalin followed by paraffin embedment were preferable to 4% paraformaldehyde fixed, quick frozen or non-fixed, quick frozen sections for demonstrating TGF-β immunoreactivity with the well characterized and highly specific rabbit polyclonal antibodies used in this study (Peress and Perillo (1994), Peress and Perillo (1995)).
Formalin fixed, paraffin embedded blocks of MS lesions were obtained
Multiple sclerosis
Multiple acute active lesions were studied from the single case with acute lesions. These lesions consisted of pale, edematous, centrally demyelinated regions encircled by cellular edges. The cellular edges were composed of an inner aspect rich in swollen macrophages (LCA and HAM 56 positive cells) encircled by a process rich glial boarder containing predominantly ramified LCA positive microglial croglial cells and some soma-rich GFAP positive astrocytes. Perivascular leukocytes, lymphocytes
Discussion
Despite evidence that TGF-β cytokines are important in the pathogenesis of immune mediated demyelination (Johns et al., 1991; Kuruvilla et al., 1991; Racke et al. (1991), Racke et al. (1992); Weinberg et al., 1992; Santambrogio et al., 1993; Johns and Sriram, 1993; Woodroofe and Cuzner, 1993; Mokhtarian et al., 1994; Link et al. (1994a), Link et al. (1994b), Link et al. (1994c), Link et al. (1995); Cannella and Raine, 1995; Correale et al., 1995), there have been only limited studies directed
Acknowledgements
This research was supported by Veterans Administration Merit Grant Funding.
References (63)
- et al.
Microglia: intrinsic immune effector cells of the brain (review)
Brain Res. Rev.
(1995) - et al.
Regulation of the transforming growth factor-beta 1 and beta 3 promoters by transcription factor Spl
Gene
(1993) - et al.
Transforming growth factor beta differentially modulates the inducible nitric oxide synthase gene in distinct cell types
Biochem. Biophys. Res. Commun.
(1993) - et al.
Brain macrophages: Questions of origin and interrelationship
Brain Res. Rev.
(1988) - et al.
Neural functions of the transforming growth factors β
Int. J. Dev. Neurosci.
(1995) - et al.
Transforming growth factor-β1 induces neuronal and astrocyte genes: Tubulin alpha 1, glial fibrillary acidic protein and clusterin
Neuroscience
(1994) - et al.
Optic neuritis is associated with myelin basic protein and proteolipid protein reactive cells producing interferon-gamma, interleukin-4 and transforming growth factor-beta
J. Neuroimmunol.
(1994) - et al.
Transforming growth factor-β1 suppresses autoantigen-induced expression of pro-inflammatory cytokines but not of interleukin-10 in multiple sclerosis and myasthenia gravis
J. Neuroimmunol.
(1995) - et al.
Enhanced expression of transforming growth factor β1 in the rat brain after a localized cererbral injury
Brain Res.
(1992) - et al.
Sulfated glycoprotein 2: new relationships of this multifunctional protein to neurodegeneration
Trends Neurosci.
(1992)
Cytokine network in the central nervous system and its roles in growth and differentiation of glial and neuronal cells
Int. J. Dev. Neurosci.
Transforming growth factor beta isoforms in the adult rat central and peripheral nervous system
Neuroscience
Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by non-radioactive in situ hybridization
Cytokine
Transforming growth factor β1 inhibits inflammatory cytokine-induced C3 gene expression in astrocytes
J. Immunol.
The adhesion molecule and cytokine profile of Multiple Sclerosis lesions
Ann. Neurol.
Differential expression of transforming growth factor-β1, -β2, and -β3 by glioblastoma cells, astrocytes, and microglia
J. Immunol.
Patterns of cytokine secretion by autoreactive proteolipid protein-specific T cell clones during the course of multiple sclerosis
J. Immunol.
Transforming growth factor-β1 modulates the expression of class II histocompatibility antigens on human cells
J. Immunol.
Transforming growth factor-beta 1 (TGF-β1) expression and regulation in rat cortical astrocytes
J. Neuroimmunol.
Immunodetection and quantitation of the two forms of transforming growth factor-Beta (TGF-β1 and TGF-β2) secreted by cells in culture
J. Cell Physiol.
Tissue inhibition of metalloproteinases (TIMP, aka EPA) structure, control of expressions and biological functions
Pharmacol. Ther.
Transforming growth factor β1 inhibits cytokine-induced CNS endothelial cell activation
Mol. Chem. Neuropathol.
TGF-β1 is an organizer of responses to neurodegeneration
J. Cell Biochem.
Altered expression of transforming growth factor-beta in Alzheimer's disease
Neurology
Cytokines regulate gelatinase A and B (Matrix Metalloproteinase 2 and 9) activity in cultured rat astrocytes
J. Neurochem.
Transforming growth factor-βs inhibit mitogen stimulated proliferation of astrocytes
Glia
Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-β1
J. Immunol.
Experimental allergic encephalomyelitis: Neutralizing antibody to TGF-β1 enhances the clinical severity of the disease
J. Neuroimmunol.
The immunopathology of Alzheimer's disease and some related disorders
Brain Pathol.
Cited by (36)
Remyelination in Multiple Sclerosis
2011, NeuroinflammationExtensive extracellular matrix depositions in active multiple sclerosis lesions
2006, Neurobiology of DiseaseT cell gene expression profiling identifies distinct subgroups of Japanese multiple sclerosis patients
2006, Journal of NeuroimmunologyTransforming growth factor-β signal transduction in epithelial cells
2001, Pharmacology and Therapeutics